Personal Statement

I obtained my doctorate in proteomics from Peking University in 2006, and then received postdoctoral training in cancer proteomics at Harvard Medical School and Boston Children's Hospital. Since 2012, I have been the director of the Mass Spectrometry and Biomarker Discovery Core and a faculty member in the Cedars-Sinai Department of Surgery and Department of Biomedical Sciences. My major research interests are to understand the molecular mechanisms underlying cancer metastasis and therapeutic resistance, and to identify novel cancer biomarkers and drug targets by developing and applying leading-edge proteomics technologies for proteome-scale analysis of protein abundance, S-acylation (palmitoylation), phosphorylation and interaction.